Appendix 4C – Quarterly Report & Company Update for the period ended 31 March 2017
170413_Appendix 4C – Quarterly Report & Company Update for the period ended 31 March 2017
170413_Appendix 4C – Quarterly Report & Company Update for the period ended 31 March 2017
170308_Dr Richard Mollard appointed as Chief Scientific Officer of PharmAust
170303_PHARMAUST RAISES A FURTHER $534k
170301_Dr Richard Hopkins Appointed as CEO of PharmAust
170131_Appendix 4C – Quarterly Report & Company Update for the period ended 31 December 2016
170130_PHARMAUST RECEIVES $406K R&D REBATE FROM ATO